European Archives - Page 866 of 1100 - European Medical Journal

Caesarean Section: A Link to Obesity

CAESAREAN sections have revolutionised modern medicine, greatly improving the survival rates of both mothers and babies. In 2013–2014, caesareans…

Improved Communication Increases Human Papillomavirus Vaccination Rates

HUMAN PAPILLOMAVIRUS (HPV) is estimated to be accountable for >90% of cervical and anal cancers, ~70% of vaginal and vulvar cancers, and >60% of penile…

Healthcare Reform: When Do We Need It and How?

Dr Maxine Szramka is a Rheumatologist in Sydney Australia. She blogs regularly at Dr Maxine Speaks10 and is a passionate advocate for the health and…

Drugs Prescribed for Type 2 Diabetes Could Protect Against Parkinson’s

GLITAZONES (GTZ), a type of drug prescribed to Type 2 diabetes patients to improve insulin sensitivity, may convey protective qualities against…

Type 1 Diabetics One Step Closer to Single Insulin Injection Per Day

GLUCOSE-RESPONSIVE insulin (GRI) has the potential to change the lives of many Type 1 diabetes mellitus patients by reducing the number of insulin…

Researchers who Discovered the Mechanisms of the Circadian Rhythm Awarded the 2017 Nobel Prize in Physiology or Medicine

“Ever since the emergence of life on Earth, about 4 billion years ago, evolving lifeforms had to adapt to the rotation of our planet. The ability to…

Who Inspires You?

Many of us look up to someone, whether it is for their achievements, skills, personality, or another reason. In a world of 7.5 billion people, in…

How to Play an Important Role in Raising Awareness for Mesothelioma in Health Education Week

Blue is the colour of hope that brings a broader awareness to a rare cancer called mesothelioma.

Introducing EMJ Cardiology 5.1

United Kingdom, October 12, 2017: European Medical Journal would like to welcome you to the latest edition of EMJ Cardiology.

MC2 Therapeutics A/S Announces First Patient Dosed in Pivotal US Phase 3 Trial in Psoriasis Vulgaris

Copenhagen, Denmark, 11 October, 2017 – MC2 Therapeutics A/S, a clinical-stage dermatology and eye care company today announced that first patient…